Opportunity Information: Apply for CDC RFA GH13 130604CONT16
Apply for CDC RFA GH13 130604CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.004.
- This funding opportunity was created on Apr 13, 2016 and posted on Apr 13, 2016.
- Applicants must submit their applications by May 16, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American," is a continuation cooperative agreement offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). The announcement is identified by Funding Opportunity Number CDC RFA GH13-130604CONT16 and is cataloged under CFDA 93.004, which is generally associated with CDC global health activities. As a continuation opportunity, it is designed to extend or continue work that is already underway rather than launch a brand-new, open competition for entirely new applicants or projects.
The core purpose of the award is to support implementation of public health programs and to strengthen public health capacity in Guatemala and the broader Central American region. In practical terms, this kind of CDC global health continuation award typically focuses on helping public health institutions and partners improve their ability to prevent, detect, and respond to health threats through stronger systems, trained workforce, better surveillance, improved laboratory capacity, and more effective program delivery. The emphasis on both "implementing programs" and "strengthening capacity" signals a dual track: delivering tangible public health interventions while also building the underlying infrastructure and institutional capabilities needed to sustain results over time.
The funding instrument is a cooperative agreement, which matters because it implies substantial involvement by CDC in the funded activities compared with a standard grant. Under a cooperative agreement model, the recipient generally carries out the day-to-day work, but CDC typically provides technical assistance, collaboration, and oversight on strategy, monitoring, evaluation, and alignment with CDC standards and public health priorities. This approach is commonly used for complex public health work where close coordination, harmonized technical guidance, and iterative problem-solving are important.
The opportunity is categorized under the activity area of Health and is listed as "Continuation" in the opportunity category, reinforcing that it is meant for ongoing efforts. The eligibility field indicates "Others (see text field entitled Additional Information on Eligibility for clarification)," which usually means eligibility is restricted or defined by additional criteria not included in the summary data. For many continuation awards, eligibility may be effectively limited to current recipients or specific partner organizations already engaged in the original project, though the definitive rules would be contained in the full announcement text.
Key administrative details include an original and current closing date of May 16, 2016, with the posting and creation date both listed as April 13, 2016. The award ceiling is shown as 0, which often indicates that a maximum funding amount is not specified in the summarized record, is variable, is determined by availability of funds, or is defined elsewhere in the full notice. The field for expected number of awards is blank in the provided data, so the summary record does not specify how many continuation awards CDC anticipated making under this posting.
Overall, this opportunity is best understood as a CDC-managed continuation cooperative agreement intended to keep forward momentum on established public health programming and capacity-building efforts in Guatemala and Central America, using a collaborative funding model where CDC remains actively engaged in technical and programmatic direction to strengthen health systems and improve public health outcomes in the region.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American."
Which agency is offering this opportunity?
This opportunity is offered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH13-130604CONT16.
What is the CFDA number associated with this opportunity?
The opportunity is cataloged under CFDA 93.004, which is generally associated with CDC global health activities.
What type of funding opportunity is this?
This is a continuation cooperative agreement. It is designed to extend or continue work that is already underway rather than launch a brand-new, open competition for entirely new applicants or projects.
What does "continuation" mean in this context?
"Continuation" indicates the funding is intended to keep forward momentum on established efforts. The summary explains that it is meant to extend or continue existing work, not to start a completely new project from scratch.
What is the main purpose of the award?
The core purpose is to support the implementation of public health programs and to strengthen public health capacity in Guatemala and the broader Central American region.
What kinds of activities does the opportunity generally support?
Based on the description provided, activities typically align with improving the ability of public health institutions and partners to prevent, detect, and respond to health threats. Examples mentioned include stronger systems, a trained workforce, better surveillance, improved laboratory capacity, and more effective program delivery.
What does it mean that the opportunity emphasizes both program implementation and capacity strengthening?
The description signals a dual track: delivering tangible public health interventions while also building the underlying infrastructure and institutional capabilities needed to sustain results over time.
What is the funding instrument, and why does it matter?
The instrument is a cooperative agreement. This matters because it implies substantial CDC involvement compared with a standard grant. The recipient typically handles day-to-day work, while CDC commonly provides technical assistance, collaboration, and oversight related to strategy, monitoring, evaluation, and alignment with CDC standards and priorities.
How involved is CDC expected to be during the project?
The summary indicates CDC is typically actively engaged under a cooperative agreement model, including collaboration and oversight on technical and programmatic direction, monitoring, and evaluation.
What is the activity area for this opportunity?
The activity area is listed as Health.
What geographic region does this opportunity focus on?
The work is focused on Guatemala and the broader Central American region.
Who is eligible to apply?
The eligibility field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)." The summary notes this usually means eligibility is restricted or defined by additional criteria that are not included in the summary data provided.
Is this opportunity likely open to entirely new applicants?
The summary explains it is a continuation opportunity designed to extend work already underway. It also notes that for many continuation awards, eligibility may be effectively limited to current recipients or specific partner organizations already engaged in the original project, though definitive rules would be in the full announcement text (not included here).
What are the key dates listed for this opportunity?
The posting and creation date are both listed as April 13, 2016. The original and current closing date is May 16, 2016.
What is the application deadline?
The current (and original) closing date is May 16, 2016.
What is the award ceiling (maximum funding amount)?
The award ceiling is shown as 0 in the summary record. The description notes this often indicates that a maximum funding amount is not specified in the summarized record, may be variable, may depend on availability of funds, or may be defined elsewhere in the full notice.
How many awards does CDC expect to make?
The expected number of awards field is blank in the provided data, so the summary record does not specify how many continuation awards were anticipated under this posting.
Is this an open competitive solicitation for new projects?
Based on the summary, it is best understood as a CDC-managed continuation cooperative agreement intended to continue established public health programming and capacity-building efforts, rather than an open competition for entirely new projects.
What is the overall goal of this continuation award?
The overall goal is to continue and strengthen public health programming and capacity-building efforts in Guatemala and Central America using a collaborative model where CDC remains actively engaged to strengthen health systems and improve public health outcomes in the region.
Browse more opportunities from the same category: Health
Next opportunity: 16.PMWRA.Project 11.Baghlan.Afghanistan.NOFO
Previous opportunity: The USAID Global Health Challenge BAA
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 130604CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 130604CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Natural History Studies for Rare Disease Product Development: Orphan Products Research Project Grant (R01) Apply for RFA FD 16 043 Funding Number: RFA FD 16 043 Agency: HHS-FDA Category: Health Funding Amount: $400,000 |
| Health Informatics Governance and Data Analytics (HIGDA) Apply for RFA 615 16 000009 Funding Number: RFA 615 16 000009 Agency: USAID-KEN Category: Health Funding Amount: $17,000,000 |
| Enhanced Access to and Utilization of Quality Family Planning/Reproductive, Maternal, Newborn, Child and Adolescent Health (FP/RMNCAH) Services in Selected Counties and Sub-counties, Kenya – (AFYA FP/RMNCAH). Apply for RFA 615 16 000007 Funding Number: RFA 615 16 000007 Agency: USAID-KEN Category: Health Funding Amount: $64,500,000 |
| NHLBI TOPMed Program: Integrative Omics Approaches for Analysis of TOPMed Data (U01) Apply for RFA HL 17 011 Funding Number: RFA HL 17 011 Agency: HHS-NIH11 Category: Health Funding Amount: $400,000 |
| New Access Points Apply for HRSA 17 009 Funding Number: HRSA 17 009 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in CDC-funded Public Health Demonstration Projects (Admin Supp) Apply for PA 16 199 Funding Number: PA 16 199 Agency: HHS-NIH11 Category: Health Funding Amount: $175,000 |
| HUMAN RESOURCES FOR HEALTH (HRH) KENYA PROGRAM Apply for RFA 615 16 000008 Funding Number: RFA 615 16 000008 Agency: USAID-KEN Category: Health Funding Amount: $38,000,000 |
| County Measurements, Learning and Accountability Program (CMLAP) Apply for RFA 615 16 000010 Funding Number: RFA 615 16 000010 Agency: USAID-KEN Category: Health Funding Amount: $17,750,000 |
| Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44) Apply for RFA HL 17 012 Funding Number: RFA HL 17 012 Agency: HHS-NIH11 Category: Health Funding Amount: $3,000,000 |
| Assisted Outpatient Treatment Grant Program for Individuals with Serious Mental Illness, (Short Title: Assisted Outpatient Treatment [AOT]) Apply for SM 16 011 Funding Number: SM 16 011 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 16 001 Funding Number: CMS 1H0 16 001 Agency: HHS-CMS Category: Health Funding Amount: $215,000 |
| Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities Apply for HHS 2016 IHS EPI 0001 Funding Number: HHS 2016 IHS EPI 0001 Agency: HHS-IHS Category: Health Funding Amount: $1,000,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Research Grant Program Apply for CMS 1I0 16 001 Funding Number: CMS 1I0 16 001 Agency: HHS-CMS Category: Health Funding Amount: $215,000 |
| Understanding HIV Rebound (P01) Apply for RFA AI 16 028 Funding Number: RFA AI 16 028 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| The Use of mRNA for an HIV Envelope Vaccine (R41/R42) Apply for PA 16 208 Funding Number: PA 16 208 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Investigator-Initiated Clinical Sequencing Research (R01) Apply for PAR 16 209 Funding Number: PAR 16 209 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Nonhuman Primate Transplantation Tolerance (U01) Apply for RFA AI 16 007 Funding Number: RFA AI 16 007 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| BioMosaic: Enhancing surveillance, detection, risk assessment and response activities using a mapping and visualization tool Apply for CDC RFA CK14 140403CONT16 Funding Number: CDC RFA CK14 140403CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS) (U24) Apply for PAR 16 205 Funding Number: PAR 16 205 Agency: HHS-NIH11 Category: Health Funding Amount: $1,100,000 |
| Nonhuman Primate Transplantation Tolerance (U19) Apply for RFA AI 16 008 Funding Number: RFA AI 16 008 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 130604CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.